Latest news
Building the Case for a National Arthritis & Musculoskeletal Research Mission
On March 30 we launched our new report, Evaluation of Preferred Investment Models for Arthritis and Musculoskeletal Research, making a powerful case for a dedicated Medical Research Future Fund (MRFF) Mission for arthritis and musculoskeletal conditions The formal launch took place at the first Parliamentary Friends of Arthritis Breakfast for 2026, with Assistant Minister Rebecca…
New Report Uncovers Alarming Lack of Research Funding into Our Leading Cause of Disability and Pain
New report recommends Medical Research Future Fund (MRFF) mission for arthritis and musculoskeletal diseases A new Research Australia report released today by Arthritis Australia confirms one of our leading causes of disability and pain – arthritis and musculoskeletal conditions (including back pain) – remains significantly deprived of research funding, despite costing the health system a…
Arthritis Australia appoints Chief Executive Officer
MEDIA RELEASE – FOR IMMEDIATE RELEASE3 February 2026 Arthritis Australia today announced the appointment of Louise Hardy as Chief Executive Officer, following her tenure as the Interim CEO since August 2025. Ms Hardy brings over a decade of experience in health policy and advocacy and a proven track record in leadership, strategic delivery, and stakeholder…
Arthritis Australia launches its first Reconciliation Action Plan
MEDIA RELEASE Arthritis Australia has proudly launched its first Reconciliation Action Plan (RAP), marking a significant milestone in the organisation’s commitment to building stronger relationships and advancing reconciliation with Aboriginal and Torres Strait Islander peoples. This Reflect RAP, endorsed by Reconciliation Australia, sets out clear actions for the next year to embed respect, increase our…
New Campaign Urges Shift to Evidence-Based OA Care for World Arthritis Day
New national campaign launches to combat misinformation and empower over 2 million Australians living with OA. In the lead-up to World Arthritis Day (12 October), a new campaign is highlighting a critical gap in osteoarthritis (OA) care: despite being the most common form of arthritis and one of the leading causes of disability globally –…
World Arthritis Day 2025
75 years of supporting people with arthritis to achieve their dreams On World Arthritis Day 2025, Arthritis Australia marks 75 years of urging the community – and decision makers – to rally behind the 7 million whose lives are shaped by arthritis and musculoskeletal conditions. For decades, arthritis and musculoskeletal (MSK) conditions have been underfunded…
Run for Stella
Stella’s story is one marked by extraordinary resilience and hope. Diagnosed with juvenile idiopathic arthritis (JIA) – later identified as rheumatoid arthritis (RA)-at age 15 during Year 9, she endured a long, uncertain year before answers finally arrived. It began with achy fingers and relentless fatigue, which her family initially blamed on “chill blaines” from…
Arthritis Australia proudly commemorates its 75th Anniversary with Prime Minister Anthony Albanese
Arthritis Australia proudly commemorates its 75th Anniversary, reflecting on a legacy of research, advocacy and progress. On September 1st, history was made at Parliament House Prime Minister Anthony Albanese and Assistant Minister for Health Rebecca White joined Parliamentary Friends of Arthritis co-chairs. national leaders, clinicians, researchers, and community advocates gathered to celebrate past achievements and…
Outdated ‘old age’ views of arthritis risk a painful and costly future, new data warns
New national poll shows close to two in three Australians are affected by arthritis or musculoskeletal conditions – either directly or through someone they know.[1] Our outdated ‘old-age’ view of arthritis persists, with almost two-thirds (63%) wrongly believing most cases occur in the 65+.1 With arthritis cases projected to rise 30% by 2040, experts warn…
Partnering for progress – Reset rheumatoid arthritis
Arthritis Australia is proud to be a key partner in the Reset RA project, which is developing immunotherapy that could revolutionise the treatment for rheumatoid arthritis. This world-leading research is being led by Professor Ranjeny Thomas AM, a rheumatologist and world-leading researcher at the University of Queensland, Translational Research Institute. Also participating are: Monash University, Macquarie University, Flinders University, University…
Sign up to Arthritis Insights
Regular updates, news and research findings delivered to your inbox:
